Man Group’s Wave Life Sciences WVE Stock Holding History

Man Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$464K	Buy	64,036 +32,618	+104%	+$425K	﹤0.01%	2107
2025 Q4	$534K	Sell	31,418 -101,353	-76%	-$1.03M	﹤0.01%	1880
2025 Q3	$972K	Buy	132,771 +73,492	+124%	+$595K	﹤0.01%	1683
2025 Q2	$385K	Buy	+59,279	New	+$391K	﹤0.01%	1908
2023 Q1	–	Sell	-17,842	Closed	-$81.8K	–	1888
2022 Q4	$125K	Buy	+17,842	New	+$82.2K	﹤0.01%	1876
2021 Q2	–	Sell	-11,415	Closed	-$64K	–	2111
2021 Q1	$64K	Sell	11,415 -75,700	-87%	-$727K	﹤0.01%	1816
2020 Q4	$686K	Buy	+87,115	New	+$731K	﹤0.01%	1487
2018 Q4	–	Sell	-5,748	Closed	-$287K	–	2139
2018 Q3	$287K	Buy	+5,748	New	+$259K	﹤0.01%	1967
2018 Q2	–	Sell	-5,458	Closed	-$219K	–	2247
2018 Q1	$219K	Buy	+5,458	New	+$229K	﹤0.01%	1908

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Man Group's WVE Position: Q1 2026 in Review

Man Group increased its Wave Life Sciences (WVE) stake by 104% in Q1 2026, buying an estimated $425K and bringing the position to 64,036 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Man Group first reported a position in WVE in Q1 2018 and has held it in 9 quarters since. The position peaked at $972K in Q3 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Man Group held 64,036 shares of Wave Life Sciences worth $464K as of Q1 2026.
Man Group bought 32,618 Wave Life Sciences shares in Q1 2026, an estimated $425K.
Wave Life Sciences made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2107 holding.
Man Group first reported a position in Wave Life Sciences in Q1 2018 and has held it in 9 quarters since.
Man Group's Wave Life Sciences position peaked at $972K in Q3 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.